JR
Javier Rodriguez
See Remarks

Javier Rodriguez insider trades: BioXcel Therapeutics (BTAI) stock sales

See Remarks, BioXcel Therapeutics Last trade May 20, 2026 26 Form 4 filings
$7K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Javier reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 20, 2026BTAI↓ Sell$7K
Dec 16, 2024BTAI↓ Sell$153
Oct 3, 2024BTAI↓ Sell$4K
Sep 16, 2024BTAI↓ Sell$238
Jun 17, 2024BTAI↓ Sell$456
Apr 4, 2024BTAI↓ Sell$3K
May 15, 2023BTAI↓ Sell10b5-1$49K
Mar 15, 2023BTAI↓ Sell10b5-1$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BTAI insiders

Open-market trades in the last 12 months

About Javier Rodriguez's insider trades

Javier Rodriguez is See Remarks at BioXcel Therapeutics (BTAI). Since Mar 15, 2023, Javier has reported no open-market purchases and 8 sales worth $82K on SEC Form 4. In the last 12 months: 1 sale ($7K).

2 sales (82% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (18 filings), grants and awards (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.